The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase 1b study of vactosertib in combination with oxaliplatin with 5FU/LV (FOLFOX) in patients with metastatic pancreatic cancer who have failed first-line gemcitabine/nab-paclitaxel.

Seung Tae  Kim

No Relationships to Disclose

Jung Yong  Hong

No Relationships to Disclose

Young Suk  Park

No Relationships to Disclose

Seong-Jin  Kim

No Relationships to Disclose

Joon Oh  Park

Consulting or Advisory Role - AstraZeneca; Celgene; MediRama; Merck Serono; SERVIER

Research Funding - Celgene; medpacto; SERVIER